FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146121613> ?p ?o ?g. }

• W2146121613 endingPage "10" @default.
• W2146121613 startingPage "3" @default.
• W2146121613 abstract "In-vitro studies in mouse oocytes have shown that the C-29 endogenously occurring sterol FF-MAS (follicular fluid meiosis-activating sterol) is a potent inducer of meiotic maturation leading to increased fertilization rates. We have used synthetic FF-MAS to induce meiotic maturation in immature human oocytes aspirated from polycystic ovarian syndrome patients. The patients were asked to give written consent to donate half of their aspirated oocytes to investigate the influence of culture conditions on maturation kinetics. The oocytes were aspirated from follicles 8-12 mm in diameter under ultrasound guidance after initial treatment with a gonadotrophin-releasing hormone agonist and s.c. injections of recombinant FSH for 3 days. The other half of the oocytes remained outside this present study. They were reserved for the patients' benefit and were fertilized with appropriate embryo stages being transferred. Fertilization and transfer were not attempted for the study oocytes. Synthetic sterol FF-MAS was added to the culture media at a concentration of 20 micromol/l and nuclear maturation was compared to a control group of oocytes cultured in media only supplemented with vehicle (TCM-199 supplemented with 0.2% ethanol v/v); thus no additional hormones, growth factors, serum or follicle fluid were added. In 31 cycles, oocytes were randomly allocated to one of seven treatment groups: fixed immediately upon aspiration (0 h group) or after in-vitro maturation culture in the presence or absence of FF-MAS for 22, 30 or 40 h respectively. A total of 81 oocytes were processed for light microscopy. The optimal timing of maturation was observed following 30 h of in-vitro culture, when 67% of FF-MAS-treated oocytes had completed nuclear maturation to the metaphase-II stage compared to 29% in the control group. The maturation time of 30 h appeared significantly superior to both 22 and 40 h, but only in the presence of FF-MAS. Cumulus expansion was most profound in the FF-MAS group after 30 h whereas all oocytes had shed the cumulus investment after 40 h. Our observations indicate that FF-MAS positively influences the absolute frequency and the kinetics of human oocytes undergoing nuclear maturation." @default.
• W2146121613 created "2016-06-24" @default.
• W2146121613 creator A5004040140 @default.
• W2146121613 creator A5008188163 @default.
• W2146121613 creator A5019852289 @default.
• W2146121613 creator A5047496959 @default.
• W2146121613 creator A5069532468 @default.
• W2146121613 date "2000-12-01" @default.
• W2146121613 modified "2023-10-01" @default.
• W2146121613 title "Human oocyte maturation in vitro is stimulated by meiosis-activating sterol" @default.
• W2146121613 cites W1585573044 @default.
• W2146121613 cites W1970464713 @default.
• W2146121613 cites W1977764079 @default.
• W2146121613 cites W1986140299 @default.
• W2146121613 cites W2001265103 @default.
• W2146121613 cites W2010184839 @default.
• W2146121613 cites W2019517102 @default.
• W2146121613 cites W2029215210 @default.
• W2146121613 cites W2034272684 @default.
• W2146121613 cites W2047401461 @default.
• W2146121613 cites W2047685450 @default.
• W2146121613 cites W2053299519 @default.
• W2146121613 cites W2055268591 @default.
• W2146121613 cites W2055754263 @default.
• W2146121613 cites W2062543923 @default.
• W2146121613 cites W2069463805 @default.
• W2146121613 cites W2077187130 @default.
• W2146121613 cites W2093315651 @default.
• W2146121613 cites W2107652116 @default.
• W2146121613 cites W2120203036 @default.
• W2146121613 cites W2120325119 @default.
• W2146121613 cites W2121608993 @default.
• W2146121613 cites W2133510032 @default.
• W2146121613 cites W2147565001 @default.
• W2146121613 cites W2149123118 @default.
• W2146121613 cites W2181729942 @default.
• W2146121613 cites W2274913454 @default.
• W2146121613 cites W2279011908 @default.
• W2146121613 cites W2332381086 @default.
• W2146121613 cites W2417137593 @default.
• W2146121613 cites W2419582398 @default.
• W2146121613 doi "https://doi.org/10.1093/humrep/15.suppl_5.3" @default.
• W2146121613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11263536" @default.
• W2146121613 hasPublicationYear "2000" @default.
• W2146121613 type Work @default.
• W2146121613 sameAs 2146121613 @default.
• W2146121613 citedByCount "34" @default.
• W2146121613 countsByYear W21461216132012 @default.
• W2146121613 countsByYear W21461216132016 @default.
• W2146121613 countsByYear W21461216132018 @default.
• W2146121613 countsByYear W21461216132019 @default.
• W2146121613 countsByYear W21461216132020 @default.
• W2146121613 countsByYear W21461216132022 @default.
• W2146121613 countsByYear W21461216132023 @default.
• W2146121613 crossrefType "journal-article" @default.
• W2146121613 hasAuthorship W2146121613A5004040140 @default.
• W2146121613 hasAuthorship W2146121613A5008188163 @default.
• W2146121613 hasAuthorship W2146121613A5019852289 @default.
• W2146121613 hasAuthorship W2146121613A5047496959 @default.
• W2146121613 hasAuthorship W2146121613A5069532468 @default.
• W2146121613 hasBestOaLocation W21461216131 @default.
• W2146121613 hasConcept C104317684 @default.
• W2146121613 hasConcept C105702510 @default.
• W2146121613 hasConcept C126322002 @default.
• W2146121613 hasConcept C134018914 @default.
• W2146121613 hasConcept C148196450 @default.
• W2146121613 hasConcept C16685009 @default.
• W2146121613 hasConcept C187785154 @default.
• W2146121613 hasConcept C196843134 @default.
• W2146121613 hasConcept C2775966511 @default.
• W2146121613 hasConcept C2776188440 @default.
• W2146121613 hasConcept C2776690073 @default.
• W2146121613 hasConcept C2777391703 @default.
• W2146121613 hasConcept C2778163477 @default.
• W2146121613 hasConcept C2778718757 @default.
• W2146121613 hasConcept C2779306644 @default.
• W2146121613 hasConcept C3018442814 @default.
• W2146121613 hasConcept C512716672 @default.
• W2146121613 hasConcept C55493867 @default.
• W2146121613 hasConcept C71924100 @default.
• W2146121613 hasConcept C86803240 @default.
• W2146121613 hasConcept C88972607 @default.
• W2146121613 hasConcept C95444343 @default.
• W2146121613 hasConceptScore W2146121613C104317684 @default.
• W2146121613 hasConceptScore W2146121613C105702510 @default.
• W2146121613 hasConceptScore W2146121613C126322002 @default.
• W2146121613 hasConceptScore W2146121613C134018914 @default.
• W2146121613 hasConceptScore W2146121613C148196450 @default.
• W2146121613 hasConceptScore W2146121613C16685009 @default.
• W2146121613 hasConceptScore W2146121613C187785154 @default.
• W2146121613 hasConceptScore W2146121613C196843134 @default.
• W2146121613 hasConceptScore W2146121613C2775966511 @default.
• W2146121613 hasConceptScore W2146121613C2776188440 @default.
• W2146121613 hasConceptScore W2146121613C2776690073 @default.
• W2146121613 hasConceptScore W2146121613C2777391703 @default.
• W2146121613 hasConceptScore W2146121613C2778163477 @default.
• W2146121613 hasConceptScore W2146121613C2778718757 @default.
• W2146121613 hasConceptScore W2146121613C2779306644 @default.

• next